Activation of the Fas/Fas ligand pathway in hypertensive renal disease in Dahl/Rapp rats

BMC Nephrology

Volumn 3, Issue , 2002, Pages 1-9

  Sanders, Paul W ^a,b   Wang, Pei Xuan ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS ANTIGEN; FAS LIGAND; PROTEIN BID; SODIUM CHLORIDE; CASP8 PROTEIN, RAT; CASPASE; LIGAND; MEMBRANE PROTEIN; TNFSF6 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIET; ENZYME ACTIVATION; GLOMERULUS; HYPERTENSION; KIDNEY EXAMINATION; KIDNEY TUBULE; NEPHROSCLEROSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SALT INTAKE; ANIMAL; DAHL SALT SENSITIVE RAT; DISEASE MODEL; DNA FRAGMENTATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 8; CASPASES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; NEPHROSCLEROSIS; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY;

EID: 3342938122     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-3-1     Document Type: Article

References (45)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988-1991. Hypertension 1995, 25:305-313
2. U.S Renal Data System: USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD.
3. Rapp JP: Dahl salt-susceptible and salt-resistant rats. Hypertension 1982, 4:753-763
4. Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 1985, 7:340-349
5. Chen PY, St. John PL, Kirk KA, Abrahamson DR, Sanders PW: Hypertensive nephrosclerosis in the Dahl/Rapp rat: initial sites of injury and effect of dietary L-arginine administration. Lab Invest 1993, 68:174-184
6. Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM: Blood pressure in blacks. Twin studies in Barbados. Hypertension 1990, 15:803-809
7. Ying W-Z, Wang P-X, Sanders PW: Induction of apoptosis during development of hypertensive nephrosclerosis. Kidney Int 2000, 58:2007-2017
8. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991, 66:233-243
9. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178
10. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997, 186:2045-2050
11. Schneider P, Holler N, Bodmer J-L, Hahne M, Frei K, Fontana A, Tschopp J: Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998, 187:1205-1213
12. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512
13. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827
14. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science (Wash DC) 1998, 281:1305-1308
15. Salveson GS, Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell 1998, 91:443-446
16. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490
17. Li H, Zhu H, Xu C-j, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501
18. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998, 17:1675-1687
19. Gonzalez-Cuadrado S, Lorz C, del Moral RG, O'Valle F, Alonso C, Ramiro F, Ortiz-Gonzalez A, Egido J, Ortiz A: Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Kidney Int 1997, 51:1739-1746
20. González-Cuadrado S, López-Armada M-J, Gómez- Guerrero C, Subirá D, Garcia-Sahuquillo A, Ortiz-Gonzalez A, Neilson EG, Egido J, Ortiz A: Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 1996, 49:1064-1070
21. Schelling JR, Nkemere N, Kopp JB, Cleveland RP: Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998, 78:813-824
22. Schelling JR, Cleveland RP: Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int 1999, 56:1313-1316
23. Lorz C, Ortiz A, Justo P, González-Cuadrado S, Duque N, Gómez-Guerrero C, Egido J: Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000, 11:1266-1277
24. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 1995, 48:1886-1892
25. Ortiz A, Lorz C, Egido J: The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 1999, 14:1831-1834
26. Ying W-Z, Sanders PW: Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats. Kidney Int 2001, 59:662-668
27. Chen PY, Sanders PW: L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991, 88:1559-1567
28. Ying W-Z, Sanders PW: Dietary salt increases endothelial nitric (oxide synthase and TGF-β;1 in rat aortic endothelium. Am J Physiol 1999, 277:H1293-H1298
29. Ying W-Z, Sanders PW: Expression of Tamm-Horsfall glycoprotein is regulated by dietary salt in rats. Kidney Int 1998, 54:1150-1156
30. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999, 104:13-19
31. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LAS: Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol Lung Cell Mol Physiol 2001, 280:L298-L305
32. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, Hara N: Protection from lethal apoptosis in lipopolysaccharide- induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2000, 157:597-603
33. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996, 49:103-111
34. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998, 53:897-908
35. Savill J, Mooney A, Hughes J: Apoptosis and renal scarring. Kidney Int 1996, 49:S-14-S-17
36. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 1998, 9:620-631
37. Khan S, Cleveland RP, Koch CJ, Schelling JR: Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 1999, 79:1089-1099
38. Hueber A-O, Zörnig M, Bernard A-M, Chautan M, Evan G: A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem 2000, 275:10453-10462
39. + cells. Nature Med 1998, 4:1377-1382
40. Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P: Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol 1999, 276:F837-F846
41. Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature (Lond) 1997, 388:300-304
42. Erl W, Hansson GK, de Martin R, Draude G, Weber KSC, Weber C: Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 1999, 84:668-677
43. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr: NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash DC) 1998, 281:1680-1683
44. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P: Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (Wash) 1998, 282:290-293
45. Chan S-W, Hegyi L, Scott S, Cary NRB, Weissberg PL, Bennett MR: Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res 2000, 86:1038-1046